Development and Shelf-Life Determination of Recombinant Interleukin-2 (Proleukin)

  • John Geigert
  • Nicholas Solli
  • Peggy Woehleke
  • Sriram Vemuri
Part of the Pharmaceutical Biotechnology book series (PBIO, volume 5)

Abstract

Human interleukin-2 (IL-2), formerly known as T cell growth factor (TCGF), is a growth and/or differentiation factor for a variety of immunologically active cells including T cells, B cells, natural killer (NK) cells, lympho-kine-activated killer cells, and macrophages (Doyle et al., 1985; Ralph et al., 1987).

Keywords

Surfactant Fermentation Rubber Oligomer Disulfide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Blackstock, W. P., Dennis, R. J., Lane, S. J., Sparks, J. I., and Weir, M. P., 1988, The analysis of recombinant interleukin-2 by thermospray liquid chromatography-mass spectrometry, Anal. Biochem. 175:319–326.PubMedCrossRefGoogle Scholar
  2. Browning, J. L., Mattaliano, R. J., Chow, E. P., Liang, S. M., Allet, B., Rosa, J., and Smart, J. E., 1986, Disulfide scrambling of interleukin-2: HPLC resolution of the three possible isomers, Anal. Biochem. 155:123–128.PubMedCrossRefGoogle Scholar
  3. Doyle, M. V., Lee, M. T., and Fong, S., 1985, Comparison of the biological activities of human recombinant interleukin-2125 and native interleukin-2, J. Biol. Response Modifiers 4:96–109.Google Scholar
  4. Fernandes, P. M., and Lundblad, J. L., 1980, Preparation of a stable intravenous gamma-globulin: Process design and scale up, Vox Sang. 39:101–112.PubMedCrossRefGoogle Scholar
  5. Fernandes, P., and Taforo, T. A., 1986, Pharmaceutical compositions of microbially produced interleukin-2, U.S. Patent No. 4,604,377.Google Scholar
  6. Ferrara, P., Pecceu, F., Marchese, E., Vita, N., Roskam, W., and Lupker, J., 1987, Characterization of recombinant glycosylated human interleukin-2 produced by a recombinant plasmid transformed CHO cell line, FEBS 226:47–52.CrossRefGoogle Scholar
  7. Fisher, B. V., and Porter, P. B., 1981, Stability of bovine insulin, J. Pharm. Pharmacol. 33:203–206.PubMedCrossRefGoogle Scholar
  8. Gearing, A. J. H., and Thorpe, R., 1988, The international standard for human IL-2: Calibration by international collaborative study, J. Immunol. Methods 114:3–9.PubMedCrossRefGoogle Scholar
  9. Grote, W., Klaar, J., Muhlradt, P. F., and Monner, D. A., 1987, Large scale production and purification of human IL-2 from buffy coat lymphocytes stimulated with 12-O-tetradecanoyl-phorbol 13-acetate and calcium ionophore A23187, J. Immunol. Methods 103:15–25.PubMedCrossRefGoogle Scholar
  10. Kato, K., Yamada, T., Kawahara, K., Onda, H., Asano, T., Sugino, H., and Kaki-numa, A., 1985, Purification and characterization of recombinant human interleukin-2 produced in Escherichia coli, Biochem. Biophys. Res. Commun. 130:692–699.PubMedCrossRefGoogle Scholar
  11. Kenny, W. C., Watson, E., Bartley, T., Boone, T., and Altrock, B. W., 1986, Parameters for the evaluation of IL-2 stability, Lymphokine Res. 5:S23-S27.Google Scholar
  12. Kunitani, M., Hirtzer, P., Johnson, D., Halenbeck, R., Boosman, A., and Koths, K., 1986, Reversed-phase chromatography of interleukin-2 muteins, J. Chroma-togr. 359:391–402.CrossRefGoogle Scholar
  13. Lahm, H. W., and Stein, S.,1985, Characterization of recombinant human interleukin-2 with micromethods, J. Chromatogr. 326:357–361.PubMedCrossRefGoogle Scholar
  14. Landgraf, B., Cohen, F. E., Smith, K. A., Gadski, R., and Ciardelli, T. L., 1989, Structural significance of the C-terminal amphophilic helix of interleukin-2, J. Biol.Chem. 264:816–822.PubMedGoogle Scholar
  15. Marchese, E., Vita, N., Maureaud, T., and Ferrara, P., 1990, Separation by cation-exchange high-performance liquid chromatography of three forms of Chinese hamster ovary cell-derived recombinant interleukin-2, J. Chromatogr. 504: 351–358.PubMedCrossRefGoogle Scholar
  16. Ralph, P., Nakoinz, L, Doyle, M., Lee, M. T., Jeong, G., Haienbeck, R., Mark, D. F., and Koths, K., 1987, Human B and T lymphocyte stimulating properties of interleukin-2 (IL-2) muteins, in: Immune Regulation by Characterized Polypeptides, Liss, New York, pp. 453–462.Google Scholar
  17. Robb, R. J., 1985, Human interleukin-2, Methods Enzymol 116:493–525.PubMedCrossRefGoogle Scholar
  18. Ross, P. D., Finlayson, J. S., and Shrake, A., 1984, Thermal stability of human albumin measured by differential scanning colorimetry, Vox Sang. 47:19–27.PubMedCrossRefGoogle Scholar
  19. Sasaoki, K., Hiroshima, T., Kusumoto, S., and Nishi, K., 1989, Oxidation of methionine residues of recombinant human interleukin-2 in aqueous solutions, Chem. Pharm. Bull. 37:2160–2164.PubMedCrossRefGoogle Scholar
  20. Tada, H., Shiho, O., Kurshima, K. I., Koyama, M., and Tsukamoto, K., 1986, An improved colorimetric assay for interleukin-2, J. Immunol. Methods 93: 157–165.PubMedCrossRefGoogle Scholar
  21. Wang, A., Lu, S. D., and Mark, D. F., 1984, Site-specific mutagenesis of the human interleukin-2 gene: Structure-function analysis of the cysteine residues, Science 224:1431–1433.PubMedCrossRefGoogle Scholar
  22. Watson, E., and Kenny, W. C., 1988, High-performance size-exclusion chromatography of recombinant derived proteins and aggregated species, J. Chromatogr. 436:289–298.PubMedCrossRefGoogle Scholar
  23. Weber, D. V., and Bailon, P., 1990, Application of receptor-affinity chromatography to bioaffinity purification, J. Chromatogr. 510:59–69.PubMedCrossRefGoogle Scholar
  24. Yamada, T., Fujishima, A., Kawahara, K., Kato, K., and Nishimura, O., 1987, Importance of disulfide linkage for constructing the biologically active human interleukin-2, Arch. Biochem. Biophys. 257:194–199f.PubMedCrossRefGoogle Scholar
  25. Yamaka, T., Kato, K. Kawahara, K., and Nishimura, O., 1986, Separation of recombinant human interleukin-2 and methionyl interleukin-2 produced in Escherichia coli, Biochem. Biophys. Res. Commun. 135:837–843.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • John Geigert
    • 1
  • Nicholas Solli
    • 1
  • Peggy Woehleke
    • 1
  • Sriram Vemuri
    • 2
  1. 1.Quality Control DepartmentChiron CorporationEmeryvilleUSA
  2. 2.Scios Nova Inc.Mountain ViewUSA

Personalised recommendations